Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Chronic-Phase × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 23 Whole-Body Irradiation 22 Peripheral Blood Stem Cell Transplantation 21 Mycophenolic Acid 21 Cyclosporine 18 Busulfan 18 Tacrolimus 15 Imatinib Mesylate 12 Antilymphocyte Serum 12 Methotrexate 11 Melphalan 10 Dasatinib 10 Cord Blood Stem Cell Transplantation 10 Cyclosporins 8 Etoposide 7 nilotinib 6 Radiotherapy 6 Methylprednisolone 6 Filgrastim 6 Sirolimus 5 Alemtuzumab 5 thymoglobulin 4 bosutinib 4 Granulocyte Colony-Stimulating Factor 4 Cytarabine 4 fludarabine 3 Thiotepa 3 Rituximab 3 Flow Cytometry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡